Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC. - Wikidata - wikimedia - TriplyDB

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

http://www.wikidata.org/entity/Q38462047

about

Ghrelin for the management of cachexia associated with cancer Palliative Care in Older Patients With Cancer A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo.STAT3 in the systemic inflammation of cancer cachexia.Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation.The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.Cancer-induced muscle wasting: latest findings in prevention and treatment.Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis.Molecular mechanism of sarcopenia and cachexia: recent research advances.Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC.Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).Cancer Cachexia: Cause, Diagnosis, and Treatment.

P2860

Q26471773-04990C02-6562-46E4-83EA-AA7ACEC5FBDC Q28085144-3143421B-F623-472E-AC23-908B38560DCD Q30827768-8E6E76B9-25DD-4B4A-B63F-EBF079FB1623 Q36901910-FCE03414-6E03-44DE-BBCB-D551132093C2 Q37030111-13299BE6-9070-4413-B0D0-0F3BE206F5D8 Q37690695-3BFAA2BB-F9EE-4AB2-AABC-93E0AFE2411B Q38670238-D415C25C-C0C1-47E3-8E02-2ABAD676DE99 Q38681113-2040390A-97A8-4C64-9AFB-1A9BE5DB6DB1 Q38772058-2EC9D08C-F392-4528-8C1A-EE69A3A3C8D8 Q39094397-B8A92D30-22CD-4379-B2BF-AB373A409A1F Q41939421-0200C0A9-E165-45D0-8952-2D54A4FB7EC9 Q47690783-E22F3C65-627B-4922-9048-7B88A2C3EB37 Q53762212-A39693A0-629E-43FF-8FFF-288A1895A007

P2860

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

http://www.wikidata.org/entity/Q38462047

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

@en

type

label

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

@en

prefLabel

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

@en

P1433

Q38462047-A739CBE4-C57F-41BE-9E0E-5243C20E25E2

P1476

Q38462047-DCCA1529-8C2E-45A0-A9CF-7DDC8A20197D

P2093

Q38462047-2C879C8F-8EF5-4017-A5F4-C7AA02AF2518

Q38462047-FC72C6C2-7DC4-4FB8-8A05-E6F9AB593658

P2860

Q38462047-004F16B4-BB53-45FB-A454-20DA1D288762

Q38462047-00EAE5BC-3FEF-43CF-A1EF-8BCF0375F24D

Q38462047-065FAEEE-14F2-407D-878A-624DCCE1FB24

Q38462047-09102172-2288-4ED1-BA98-2BF3AE6FFABD

Q38462047-0CCDAA21-8441-4031-A82D-EC1E57E26D19

Q38462047-0FF581BA-C697-47FC-82CD-FBB632AD047E

Q38462047-13F219F0-DEED-48A0-9AB8-14F6C22BB45D

Q38462047-14D46A35-9F88-4339-B1F5-860EFE2B0E40

Q38462047-1609C7B0-10E9-41DA-9203-BE241F0247B8

Q38462047-17B3004D-0056-45ED-944B-AE0CD0D99E40

P304

Q38462047-1D99C60B-C826-479F-8DA0-B5EB2289FF51

P31

Q38462047-C5484A78-CE2F-4EC1-A76D-47653CD26E34

P356

Q38462047-AA78C769-8B39-4CF8-B32C-160503CB0AB6

P407

Q38462047-63DBED93-57C9-41B3-A42D-52C090FBE410

P433

Q38462047-D122E8F1-4941-49AC-822E-B64338640444

P478

Q38462047-B03D363B-664C-4F5A-B005-C23ACC8C59E9

P577

Q38462047-3A45D3A6-DAF1-4D96-A6E3-59D34DDE435E

P698

Q38462047-B91E16C7-3BE5-4435-A163-43825C7BF168

P932

Q38462047-3CE003FB-9496-43C5-9668-23D3E0DB2DB8

P356

14656566.2015.1041500

P1433

Expert Opinion on Pharmacotherapy

P1476

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

@en

P2093

Hongjie Zhang

http://www.w3.org/2001/XMLSchema#string

Jose M Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia

Mechanisms in endocrinology: regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions

Ghrelin--a hormone with multiple functions

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.

Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice

Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.

P304

1245-1253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1041500

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25945893

http://www.w3.org/2001/XMLSchema#string

P932

4677053

http://www.w3.org/2001/XMLSchema#string